Literature DB >> 32572858

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020.

Cesare Hassan1, Giulio Antonelli1, Jean-Marc Dumonceau2, Jaroslaw Regula3, Michael Bretthauer4, Stanislas Chaussade5, Evelien Dekker6, Monika Ferlitsch7, Antonio Gimeno-Garcia8, Rodrigo Jover9, Mette Kalager4, Maria Pellisé10, Christian Pox11, Luigi Ricciardiello12, Matthew Rutter13, Lise Mørkved Helsingen4, Arne Bleijenberg6, Carlo Senore14, Jeanin E van Hooft6, Mario Dinis-Ribeiro15, Enrique Quintero8.   

Abstract

The following recommendations for post-polypectomy colonoscopic surveillance apply to all patients who had one or more polyps that were completely removed during a high quality baseline colonoscopy. 1: ESGE recommends that patients with complete removal of 1 - 4 < 10 mm adenomas with low grade dysplasia, irrespective of villous components, or any serrated polyp < 10 mm without dysplasia, do not require endoscopic surveillance and should be returned to screening.Strong recommendation, moderate quality evidence.If organized screening is not available, repetition of colonoscopy 10 years after the index procedure is recommended.Strong recommendation, moderate quality evidence. 2: ESGE recommends surveillance colonoscopy after 3 years for patients with complete removal of at least 1 adenoma ≥ 10 mm or with high grade dysplasia, or ≥ 5 adenomas, or any serrated polyp ≥ 10 mm or with dysplasia. Strong recommendation, moderate quality evidence. 3: ESGE recommends a 3 - 6-month early repeat colonoscopy following piecemeal endoscopic resection of polyps ≥ 20 mm.Strong recommendation, moderate quality evidence. A first surveillance colonoscopy 12 months after the repeat colonoscopy is recommended to detect late recurrence.Strong recommendation, high quality evidence. 4: If no polyps requiring surveillance are detected at the first surveillance colonoscopy, ESGE suggests to perform a second surveillance colonoscopy after 5 years. Weak recommendation, low quality evidence.After that, if no polyps requiring surveillance are detected, patients can be returned to screening. 5: ESGE suggests that, if polyps requiring surveillance are detected at first or subsequent surveillance examinations, surveillance colonoscopy may be performed at 3 years. Weak recommendation, low quality evidence.A flowchart showing the recommended surveillance intervals is provided (Fig. 1). © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2020        PMID: 32572858     DOI: 10.1055/a-1185-3109

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  40 in total

1.  Polypectomy and the Efficacy and Safety of Postpolypectomy Clipping.

Authors:  Heiko Pohl
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-09

2.  Analysis of dynamic molecular networks: the progression from colorectal adenoma to cancer.

Authors:  Yuchen Jiang; Feifeng Song; Xiaoping Hu; Dandan Guo; Yujia Liu; Jiafeng Wang; Liehao Jiang; Ping Huang; Yiwen Zhang
Journal:  J Gastrointest Oncol       Date:  2021-12

3.  Adenocarcinoma occurring from a sigmoid colostomy 20 years after Hartmann's procedure for rectal cancer: A case report.

Authors:  Yusuke Kitagawa; Shigeo Hirasaki; Michiya Bando
Journal:  Int J Surg Case Rep       Date:  2021-12-06

4.  A progressive three-state model to estimate time to cancer: a likelihood-based approach.

Authors:  Eddymurphy U Akwiwu; Thomas Klausch; Henriette C Jodal; Beatriz Carvalho; Magnus Løberg; Mette Kalager; Johannes Berkhof; Veerle M H Coupé
Journal:  BMC Med Res Methodol       Date:  2022-06-27       Impact factor: 4.612

5.  Somatic Mutations in Exon 7 of the TP53 Gene in Index Colorectal Lesions Are Associated with the Early Occurrence of Metachronous Adenoma.

Authors:  Tereza Hálková; Renata Ptáčková; Anastasiya Semyakina; Štěpán Suchánek; Eva Traboulsi; Ondřej Ngo; Kateřina Hejcmanová; Ondřej Májek; Jan Bureš; Miroslav Zavoral; Marek Minárik; Lucie Benešová
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

6.  Randomised comparison of postpolypectomy surveillance intervals following a two-round baseline colonoscopy: the Japan Polyp Study Workgroup.

Authors:  Takahisa Matsuda; Takahiro Fujii; Yasushi Sano; Shin-Ei Kudo; Yasushi Oda; Kinichi Hotta; Tadakazu Shimoda; Yutaka Saito; Nozomu Kobayashi; Masau Sekiguchi; Kazuo Konishi; Hiroaki Ikematsu; Hiroyasu Iishi; Yoji Takeuchi; Masahiro Igarashi; Kiyonori Kobayashi; Miwa Sada; Yuichiro Yamaguchi; Kiwamu Hasuda; Tomoaki Shinohara; Hideki Ishikawa; Yoshitaka Murakami; Hirokazu Taniguchi; Takahiro Fujimori; Yoichi Ajioka; Shigeaki Yoshida
Journal:  Gut       Date:  2020-11-02       Impact factor: 23.059

Review 7.  Post-polypectomy surveillance colonoscopy: Comparison of the updated guidelines.

Authors:  Naim Abu-Freha; Lior H Katz; Revital Kariv; Elez Vainer; Ido Laish; Nathan Gluck; Elizabeth E Half; Zohar Levi
Journal:  United European Gastroenterol J       Date:  2021-06-02       Impact factor: 4.623

8.  Metachronous neoplasms in patients with laterally spreading tumours during surveillance.

Authors:  Roel M M Bogie; Bjorn Winkens; Sean J J Retra; Chantal M C le Clercq; Mariëlle W Bouwens; Eveline J A Rondagh; Li-Chun Chang; Rogier de Ridder; Chantal Hoge; Jan-Willem Straathof; Danny Goudkade; Silvia Sanduleanu-Dascalescu; Ad A M Masclee
Journal:  United European Gastroenterol J       Date:  2021-02-18       Impact factor: 4.623

Review 9.  The histomorphological and molecular landscape of colorectal adenomas and serrated lesions.

Authors:  Francesca Galuppini; Matteo Fassan; Luca Mastracci; Roberta Gafà; Marcello Lo Mele; Stefano Lazzi; Andrea Remo; Paola Parente; Alessandro D'Amuri; Claudia Mescoli; Fabiana Tatangelo; Giovanni Lanza
Journal:  Pathologica       Date:  2021-06

10.  Practice Patterns and Predictors of Stopping Colonoscopy in Older Adults With Colorectal Polyps.

Authors:  Soham Rege; Elliot Coburn; Douglas J Robertson; Audrey H Calderwood
Journal:  Clin Gastroenterol Hepatol       Date:  2021-06-30       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.